fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 1 Sep 2026

UBL, full dossier

United Breweries Ltd sees positive demand momentum in Q2 driven by growth in premium brands and maintains its FY27 outlook of double-digit revenue growth with premium brands portfolio expected to grow over 20 percent.

2 publishers have reported this development. Each act of reporting is below, cited.

The record

United Breweries Ltd sees positive demand momentum in Q2 driven by growth in premium brands and maintains its FY27 outlook of double-digit revenue growth with premium brands portfolio expected to grow over 20 percent.

indiatimes.com1 Sep 2026

United Breweries Ltd maintains its FY27 outlook of double-digit revenue growth with premium brands portfolio expected to grow over 20 per cent, and has invested 110 crore in a new canning line at its Ellora Brewery in Maharashtra.

thehindubusinessline.com1 Sep 2026

United Breweries

₹1,188.80

▲ +2.65%

Close (EOD), as of 1 Oct 2026 · source

United Breweries: results, dividends, orders, the full cited record →

More on United Breweries

Uttar Pradesh is attracting over Rs 1,000 crore in private investment in the downstream supply chain, including distilleries and manufacturing units.

29 Sep 2026 · 1 publisher

At around ₹1,249, United Breweries has fallen another 29 per cent since March and is about 46 per cent below the ₹2,299 all-time high.

20 Sep 2026 · 1 publisher

United Breweries has devised a medium-term plan to achieve double-digit revenue growth and a low-teen operating profit margin.

14 Sep 2026 · 1 publisher

Shares of United Breweries fell 3.1% on Tuesday, September 8, to hit their 52-week low.

8 Sep 2026 · 1 publisher

United Breweries Ltd (UBL) stock hit a new 52-week low of ₹ 1,275.30 on Monday.

7 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.